BPH Global Limited (BP8)

Overview

BPH Global Ltd is a distinguished organization active in the fields of sourcing, producing, marketing, and selling traditional medicines. This company has a strong presence in Australia, Singapore, China, and Malaysia, demonstrating its extensive international operations. With origins dating back to 1984 and initially established as Stemcell United Limited, the organization underwent a significant rebranding in June 2023, adopting its current name, BPH Global Ltd. The headquarters of this rebranded entity are strategically located in Melbourne, Australia, serving as the central hub for its widespread activities in traditional medicinal products.

Products and Services

The product portfolio of BPH Global Ltd is diverse, encompassing a variety of traditional medicines derived from natural sources:

• Caulerpa Lentillifera: Also known as sea grape extract, this product is a testament to the company’s commitment to leveraging the therapeutic potential of marine resources. The use of Caulerpa Lentillifera is notable for its nutritional benefits and is a popular component in dietary supplements.
• Dendrobium Officinale Kimura et Migo: This product is derived from a specific orchid species and is revered for its wide range of applications in traditional Chinese medicine. Its purported health benefits include boosting the immune system and improving stomach health.
• Resina Daemonorops Draco Blume: An extract obtained from the resin of the Draco Blume plant, this substance is traditionally utilized for its anti-inflammatory and analgesic properties, showcasing the company’s exploration into plant-based medicinal products.
• Cannabis Sativa: Known as industrial hemp, this product underscores BPH Global Ltd’s venture into the cultivation and processing of hemp for medicinal purposes. The use of Cannabis Sativa is closely regulated, aiming to tap into its potential benefits in various medical applications.